Survival in Patients with Non-small Cell Lung Cancer and Brain Metastases and QUARTZ in Practice

被引:1
|
作者
Bradley, K. L. [1 ]
Lwin, M. T. [1 ]
Laurence, V. M. [1 ]
机构
[1] NHS Fdn Trust, Dorset Canc Ctr, Poole Hosp, Poole BH15 2JB, Dorset, England
关键词
D O I
10.1016/j.clon.2010.06.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
下载
收藏
页码:892 / 892
页数:1
相关论文
共 50 条
  • [41] Systemic treatment of non-small cell lung cancer brain metastases
    Cedrych, Ida
    Kruczala, Maksymilian A.
    Walasek, Tomasz
    Jakubowicz, Jerzy
    Blecharz, Pawel
    Reinfuss, Marian
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2016, 20 (05): : 352 - 357
  • [42] The Immune Microenvironment in Brain Metastases of Non-Small Cell Lung Cancer
    Luo, Lumeng
    Liu, Peiyi
    Zhao, Kuaile
    Zhao, Weixin
    Zhang, Xiaofei
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [43] Management of brain metastases from non-small cell lung cancer
    Baykara, Meltem
    Kurt, Gokhan
    Buyukberber, Suleyman
    Demirci, Umut
    Ceviker, Necdet
    Algin, Efnan
    Coskun, Ugur
    Aykol, Sukru
    Emmez, Hakan
    Ozet, Ahmet
    Benekli, Mustafa
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2014, 10 (04) : 915 - 921
  • [44] An examination of the recruitment of non-small cell lung cancer (NSCLC) patients with brain metastases (BM) to the QUARTZ Clinical Trial at the Christie
    Helbrow, J.
    Bayman, N.
    Burt, P. A.
    Chittalia, A.
    Harris, M.
    Lander, H.
    Lee, L. W.
    Pemberton, L.
    Sheikh, H. Y.
    Malloy, L.
    Faivre-Finn, C.
    LUNG CANCER, 2011, 71 : S37 - S37
  • [45] ANALYSIS OF GEFITINIB ON BRAIN METASTASES IN PATIENTS WITH NON-SMALL LUNG CANCER
    Baihao, H.
    RESPIROLOGY, 2011, 16 : 132 - 132
  • [46] Clinical determinants impacting overall survival of patients with operable brain metastases from non-small cell lung cancer
    Piffko, Andras
    Asey, Benedikt
    Duehrsen, Lasse
    Ristow, Inka
    Salamon, Johannes
    Wikman, Harriet
    Maire, Cecile L.
    Lamszus, Katrin
    Westphal, Manfred
    Sauvigny, Thomas
    Mohme, Malte
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [47] Survival Benefit From Immunocheckpoint Inhibitors in Stage IV Non-Small Cell Lung Cancer Patients With Brain Metastases
    Takamori, S.
    Komiya, T.
    Powell, E.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S575 - S576
  • [48] Survival in Patients with ≥5 Brain Metastases From Non-Small Cell Lung Cancer Treated With Upfront Stereotactic Radiosurgery
    Gurewitz, J.
    Patel, D.
    Benjamin, C.
    Donahue, B. R.
    Silverman, J.
    Mureb, M.
    Bernstein, K.
    Kondziolka, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E567 - E568
  • [49] EGFR mutation status and its impact on survival of Chinese non-small cell lung cancer patients with brain metastases
    Luo, Dongdong
    Ye, Xin
    Hu, Zheng
    Peng, Kaiwen
    Song, Ye
    Yin, Xiaolu
    Zhu, Guanshan
    Ji, Qunsheng
    Peng, Yuping
    TUMOR BIOLOGY, 2014, 35 (03) : 2437 - 2444
  • [50] Impact of Locoregional Therapies for Brain Lesions on Survival in Patients With Non-small Cell Lung Cancer With Multiple Extrathoracic Metastases
    Sakai, Kosuke
    Kuramoto, Joji
    Takahashi, Tomoyuki
    Kawano, Yuichiro
    Nishimura, Hiroaki
    Kuwabara, Yoshiki
    Kojima, Akitoshi
    Sasaki-toda, Maiko
    Ogawa-Kobayashi, Yumiko
    Kikuchi, Satoshi
    Hirata, Yusuke
    Mikami-Saito, Yuriko
    Mikami, Shintaro
    Kyoyama, Hiroyuki
    Moriyama, Gaku
    Koyama, Nobuyuki
    Uematsu, Kazutsugu
    ANTICANCER RESEARCH, 2023, 43 (11) : 5107 - 5114